Medicare and Medicaid Programs; Continued Approval of the American Association for Accreditation of Ambulatory Surgery Facilities' Rural Health Clinic Accreditation Program, 16003-16005 [2022-05910]
Download as PDF
Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a
virtual meeting and is open to the
public. Advance registration by April
28, 2022, is needed to receive the
information to join the meeting. The
registration link is provided in the
ADDRESSES section below.
DATES: The meeting will be held on May
12, 2022, from 9:00 a.m. to 4:30 p.m.,
EDT.
SUMMARY:
Register in advance at
https://www.zoomgov.com/webinar/
register/WN_
JpapSgFXRKmeHVU9hW4jVQ to
receive information to join the meeting.
FOR FURTHER INFORMATION CONTACT:
Alexis Pullia, M.P.H., C.P.H., Committee
Management Specialist, National Center
for Environmental Health, CDC, 4770
Buford Highway, Atlanta, Georgia
30341, Telephone: 770–488–3300;
Email: LEPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and
Prevention Advisory Committee was
established under Section 2203 of
Public Law 114–322, the Water
Infrastructure Improvements for the
Nation Act; 42 U.S.C. 300j-21, Registry
for Lead Exposure and Prevention
Advisory Committee.
Purpose: The LEPAC is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), and the
Director, CDC and Administrator,
ATSDR, on (1) reviewing Federal
programs and services available to
individual communities exposed to
lead; (2) reviewing current research on
lead exposure to identify additional
research needs; (3) reviewing and
identifying best practices, or the need
for best practices regarding lead
screening and the prevention of lead
poisoning; (4) identifying effective
services, including services relating to
healthcare, education, and nutrition for
individuals and communities affected
by lead exposure and lead poisoning,
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
21:01 Mar 18, 2022
Jkt 256001
including in consultation with, as
appropriate, the lead exposure registry
as established in Section 2203(b) of
Public Law 114–322; and 5) undertaking
any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda
will include updates on the Flint Lead
Registry and lead-related activities from
LEPAC Members; information on lead
exposure in Clarksburg, West Virginia;
and discussions on the following:
Infrastructure initiatives related to lead;
lead in air, soil, and blood; navigating
multiple funding streams at the local
level; and policy approaches to improve
childhood blood lead testing rates.
Agenda items are subject to change as
priorities dictate.
Public Participation
Oral Public Comment: The public
comment period is scheduled on May
12, 2022, from 12:00 p.m. until 12:15
p.m., EDT. Individuals wishing to make
a comment during the public comment
period, please email your name,
organization, and phone number by
April 28, 2022, to LEPAC@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–05801 Filed 3–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3416–FN]
Medicare and Medicaid Programs;
Continued Approval of the American
Association for Accreditation of
Ambulatory Surgery Facilities’ Rural
Health Clinic Accreditation Program
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services (HHS).
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve the American
Association for Accreditation of
SUMMARY:
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
16003
Ambulatory Surgery Facilities
(AAAASF) for continued recognition as
a national accrediting organization for
Rural Health Clinics (RHCs) that wish to
participate in the Medicare or Medicaid
programs.
DATES: The decision in this final notice
is effective March 23, 2022, through
March 23, 2026.
FOR FURTHER INFORMATION CONTACT:
Lillian Williams, (410) 786–8636, or
Shonte Carter, (410) 786–3532.
SUPPLEMENTARY INFORMATION:
I. Background
A healthcare provider may enter into
an agreement with Medicare to
participate in the program as a Rural
Health Clinic (RHC) provided certain
requirements are met. Section
1861(aa)(2) and 1905(l)(1)of the Social
Security Act (the Act), establish distinct
criteria for facilities seeking designation
as RHCs for Medicare and Medicaid,
respectively. Regulations concerning
Medicare provider agreements are at 42
CFR part 489 and those pertaining to the
survey and certification for Medicare
participation of certain providers and
suppliers are at 42 CFR part 488. The
regulations at 42 CFR part 491 specify
the conditions that a facility must meet
to participate in the Medicare program
as an RHC.
Generally, to enter into a Medicare
provider agreement, an RHC must first
be certified by a State survey agency as
complying with the conditions set forth
in part 491 of our Medicare regulations.
Thereafter, the RHC is subject to
periodic surveys by a State survey
agency to determine whether it
continues to meet these conditions.
However, there is an alternative to
certification surveys by State agencies.
Accreditation by an approved,
nationally recognized Medicare
accreditation program may substitute for
both initial and ongoing review.
Section 1865(a)(1) of the Act provides
that, if the Secretary of the Department
of Health and Human Services finds that
accreditation of a provider entity by an
approved national accreditation
organization demonstrates that all
applicable Medicare conditions or
requirements are met or exceeded, we
will deem those provider entities as
having met such requirements.
Accreditation by an accrediting
organization is voluntary and is not
required for Medicare participation.
Subpart A of part 488 requires in part
that a national accrediting organization
applying for approval of its Medicare
accreditation program provide us with
reasonable assurance that the
accrediting organization requires its
E:\FR\FM\21MRN1.SGM
21MRN1
16004
Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices
accredited provider entities to meet
requirements that are at least as
stringent as the Medicare conditions.
Our regulations concerning the approval
of accrediting organizations are set forth
at § 488.5. Section 488.5(e)(2)(i) requires
an accrediting organization to reapply
for continued approval of its Medicare
accreditation program every 6 years or
sooner as determined by CMS. The
American Association for Accreditation
of Ambulatory Surgery Facilities’
(AAAASF) current term of approval for
their RHC accreditation program expires
March 23, 2022.
khammond on DSKJM1Z7X2PROD with NOTICES
II. Application Approval Process
Section 1865(a)(3)(A) of the Act
requires that we publish, within 60 days
of receipt of an organization’s complete
application, a notice identifying the
national accreditation body making the
request, describing the nature of the
request, and providing at least a 30-day
public comment period. We have 210
days after the date of receipt of a
complete application to publish a notice
announcing our approval or denial of an
application.
III. Provisions of the Proposed Notice
On October 15, 2021, we published a
proposed notice in the Federal Register
(86 FR 57429) entitled ‘‘Application
from the American Association for
Accreditation of Ambulatory Surgery
Facilities for Continued Approval of its
Rural Health Clinic (RHC) Accreditation
Program’’ announcing AAAASF’s
request for continued approval of its
Medicare RHC accreditation program. In
that notice, we detailed our evaluation
criteria. Under section 1865(a)(2) of the
Act and per §§ 488.5 and 488.8(h), we
conducted a review of AAAASF’s
application in accordance with the
criteria authorized by our regulations,
which include, but are not limited to the
following:
• An administrative review of
AAAASF’s: (1) Corporate policies; (2)
financial and human resources available
to accomplish the proposed surveys; (3)
procedures for training, monitoring, and
evaluation of its RHC surveyors; (4)
ability to investigate and respond
appropriately to complaints against
accredited RHCs; and, (5) survey review
and decision-making process for
accreditation.
• The equivalency of AAAASF’s
standards for RHCs as compared with
CMS’ RHC CoPs.
• AAAASF’s survey process to
determine the following:
++ The composition of the survey
team, surveyor qualifications, and the
ability of the organization to provide
continuing survey training.
VerDate Sep<11>2014
21:01 Mar 18, 2022
Jkt 256001
++ The comparability of AAAASF’s
processes to those of State agencies,
including survey frequency, and the
ability to investigate and respond
appropriately to complaints against
accredited RHCs.
++ AAAASF processes and
procedures for monitoring RHCs found
out of compliance with AAAASF’s
program requirements. These
monitoring procedures are used only
when AAAASF identifies
noncompliance. If noncompliance is
identified through validation reviews or
complaint surveys, the State survey
agency monitors corrections as specified
at § 488.9(c).
++ AAAASF’s capacity to report
deficiencies to the surveyed RHCs and
respond to the RHC’s plan of correction
in a timely manner.
++ AAAASF’s capacity to provide us
with electronic data and reports
necessary for effective validation and
assessment of the organization’s survey
process.
++ The adequacy of AAAASF’s staff
and other resources, and its financial
viability.
++ AAAASF’s capacity to adequately
fund required surveys.
++ AAAASF’s policies with respect
to whether surveys are announced or
unannounced, to assure that surveys are
unannounced.
++ AAAASF’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ AAAASF’s agreement to provide
us with a copy of the most current
accreditation survey together with any
other information related to the survey
as we may require, including corrective
action plans.
In accordance with section
1865(a)(3)(A) of the Act, the October 15,
2021 proposed notice also solicited
public comments regarding whether
AAAASF’s requirements met or
exceeded the Medicare conditions for
certification for RHCs. The comments
we received support the approval of
AAAASF for continued recognition as a
national accrediting organization for
RHCs. We did not receive any
comments opposing the approval.
IV. Provisions of the Final Notice
A. Differences Between AAAASF’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared AAAASF’s RHC
accreditation requirements and survey
process with the Medicare conditions
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
for certification of 42 CFR part 491 and
the survey and certification process
requirements of parts 488 and 489. Our
review and evaluation of AAAASF’s
RHC application, which were conducted
as described in section III. of this final
notice, yielded the following areas
where, as of the date of this notice,
AAAASF has completed revising its
standards and survey processes in order
to meet the requirements at:
• Section 491.7(a)(1) to ensure that
their crosswalk and standards included
the requirement that an RHC must have
a health care staff that meets the
requirements of § 491.8.
• Section 491.8(a)(2) to ensure that
their crosswalk and standards include
the correct reference that a physician
member of the staff may be the owner
of the RHC, an employee of the clinic
or center, or under agreement with the
clinic or center to carry out the
responsibilities required under this
section.
• Section 491.9(b)(4) to include the
correct reference to § 491.9(b)(2),
identifying the group of professional
personnel.
• Section 491.9(c)(2) to include a
reference to 42 CFR part 493.
• Revised and clarified survey
processes and organizational policies,
consistent with § 488.5(a)(4)(i), to
ensure all surveys are unannounced.
AAAASF clarified its organizational
policies to reflect that surveys are not
conducted based on the availability of
administrators, clinic directors, or any
other individual of authority, and for
the same reasons, are not delayed.
In accordance with comparability
requirements to those of the State
Survey Agency at § 488.5(a)(4)(ii),
AAAASF’s revised its policies,
procedures and survey processes to
include:
• Revising policies to ensure the
sample of the medical records used in
surveyor guidance is consistent with the
type of medical records to be reviewed.
• Providing a corrective action plan
and clarifications to AAAASF’s policies
to ensure that documentation of patient
and staff observations and record
reviews include separate identifier keys
used to ensure the security of patients
and staff.
• Developing additional policies and
procedures and surveyor guides to
clarify deficiency citations, specifically
how surveyors determine the
appropriateness of the level of citation
is assessed during an RHC survey for
compliance (that is, condition level v.
standard level deficiency citation) and
in accordance with § 488.26(b).
• Section 488.5(a)(5) describing the
method AAAASF uses for determining
E:\FR\FM\21MRN1.SGM
21MRN1
Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices
the size and composition of the RHC
survey team and AAAASF’s comparable
criteria on determining the parameters
for each survey to be comparable to
those of the State Survey Agency as
outlined per § 488.5(a)(4).
Dated: March 16, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2022–05910 Filed 3–18–22; 8:45 am]
BILLING CODE 4120–01–P
B. Term of Approval
Based on our review and observations
described in section III. of this final
notice, we approve AAAASF as a
national accreditation organization for
RHCs that request participation in the
Medicare program. The decision
announced in this final notice is
effective March 23, 2022 through March
23, 2026. Due to travel restrictions and
the reprioritization of survey activities
brought on by the 2019 Novel
Coronavirus Disease (COVID–19) Public
Health Emergency (PHE), CMS was
unable to observe an RHC survey
completed by AAAASF surveyors as
part of the application review process,
which is typically one component of the
comparability evaluation. Therefore, we
are providing AAAASF with a shorter
period of approval. Based on our
discussions with AAAASF and the
information provided in its application,
we are confident that AAAASF will
continue to ensure that its accredited
RHCs will continue to meet or exceed
the required standards. While AAAASF
has taken actions based on the findings
noted in section IV. of this final notice
(Differences Between AAAASF’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements), as
authorized under § 488.8, we will
continue ongoing review of AAAASF’s
RHC survey processes and will conduct
a survey observation once the COVID–
19 PHE has expired.
khammond on DSKJM1Z7X2PROD with NOTICES
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Lynette Wilson, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
VerDate Sep<11>2014
21:01 Mar 18, 2022
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–N–0412]
Revocation of Authorization of
Emergency Use of an In Vitro
Diagnostic Device for Detection and/or
Diagnosis of COVID–19; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
revocation of the Emergency Use
Authorization (EUA) (the Authorization)
issued to Abbott Diagnostics
Scarborough, Inc. (Abbott) for the
BinaxNOW COVID–19 Ag Card 2 Home
Test. FDA revoked this Authorization
under the Federal Food, Drug, and
Cosmetic Act (FD&C Act). The
revocation, which includes an
explanation of the reasons for
revocation, is reprinted in this
document.
DATES: The Authorization for the
BinaxNOW COVID–19 Ag Card 2 Home
Test is revoked as of February 24, 2022.
ADDRESSES: Submit a written request for
a single copy of the revocation to the
Office of Counterterrorism and
Emerging Threats, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 1, Rm. 4338, Silver Spring,
MD 20993–0002. Send one selfaddressed adhesive label to assist that
office in processing your request or
include a Fax number to which the
revocation may be sent. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the revocation.
FOR FURTHER INFORMATION CONTACT:
Jennifer J. Ross, Office of
Counterterrorism and Emerging Threats,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 1, Rm.
4332, Silver Spring, MD 20993–0002,
240–402–8155 (this is not a toll-free
number).
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Section 564 of the FD&C Act (21
U.S.C. 360bbb–3) as amended by the
Project BioShield Act of 2004 (Pub. L.
108–276) and the Pandemic and All-
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
16005
Hazards Preparedness Reauthorization
Act of 2013 (Pub. L. 113–5) allows FDA
to strengthen the public health
protections against biological, chemical,
nuclear, and radiological agents. Among
other things, section 564 of the FD&C
Act allows FDA to authorize the use of
an unapproved medical product or an
unapproved use of an approved medical
product in certain situations. On March
31, 2021, FDA issued an EUA to Abbott
for the BinaxNOW COVID–19 Ag Card
2 Home Test, subject to the terms of the
Authorization. Notice of the issuance of
this Authorization was published in the
Federal Register on July 23, 2021 (86 FR
39040), as required by section 564(h)(1)
of the FD&C Act. Subsequent updates to
the Authorization were made available
on FDA’s website. The authorization of
a device for emergency use under
section 564 of the FD&C Act may,
pursuant to section 564(g)(2) of the
FD&C Act, be revoked when the criteria
under section 564(c) of the FD&C Act for
issuance of such authorization are no
longer met (section 564(g)(2)(B) of the
FD&C Act), or other circumstances make
such revocation appropriate to protect
the public health or safety (section
564(g)(2)(C) of the FD&C Act).
II. EUA Revocation Request
In a request received by FDA on
February 21, 2022, Abbott requested
revocation of, and on February 24, 2022,
FDA revoked, the Authorization for the
BinaxNOW COVID–19 Ag Card 2 Home
Test. Because Abbott notified FDA that
the EUA for BinaxNOW COVID–19 Ag
Card 2 Home Test is no longer required
and requested FDA revoke the EUA for
the BinaxNOW COVID–19 Ag Card 2
Home Test, FDA has determined that it
is appropriate to protect the public
health or safety to revoke this
Authorization.
III. Electronic Access
An electronic version of this
document and the full text of the
revocation is available on the internet at
https://www.regulations.gov/.
IV. The Revocation
Having concluded that the criteria for
revocation of the Authorization under
section 564(g)(2)(C) of the FD&C Act are
met, FDA has revoked the EUA of
Abbott for the BinaxNOW COVID–19 Ag
Card 2 Home Test. The revocation in its
entirety follows and provides an
explanation of the reasons for
revocation, as required by section
564(h)(1) of the FD&C Act.
BILLING CODE 4164–01–P
E:\FR\FM\21MRN1.SGM
21MRN1
Agencies
[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Pages 16003-16005]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05910]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3416-FN]
Medicare and Medicaid Programs; Continued Approval of the
American Association for Accreditation of Ambulatory Surgery
Facilities' Rural Health Clinic Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services, Department of Health
and Human Services (HHS).
ACTION: Final notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces our decision to approve the
American Association for Accreditation of Ambulatory Surgery Facilities
(AAAASF) for continued recognition as a national accrediting
organization for Rural Health Clinics (RHCs) that wish to participate
in the Medicare or Medicaid programs.
DATES: The decision in this final notice is effective March 23, 2022,
through March 23, 2026.
FOR FURTHER INFORMATION CONTACT: Lillian Williams, (410) 786-8636, or
Shonte Carter, (410) 786-3532.
SUPPLEMENTARY INFORMATION:
I. Background
A healthcare provider may enter into an agreement with Medicare to
participate in the program as a Rural Health Clinic (RHC) provided
certain requirements are met. Section 1861(aa)(2) and 1905(l)(1)of the
Social Security Act (the Act), establish distinct criteria for
facilities seeking designation as RHCs for Medicare and Medicaid,
respectively. Regulations concerning Medicare provider agreements are
at 42 CFR part 489 and those pertaining to the survey and certification
for Medicare participation of certain providers and suppliers are at 42
CFR part 488. The regulations at 42 CFR part 491 specify the conditions
that a facility must meet to participate in the Medicare program as an
RHC.
Generally, to enter into a Medicare provider agreement, an RHC must
first be certified by a State survey agency as complying with the
conditions set forth in part 491 of our Medicare regulations.
Thereafter, the RHC is subject to periodic surveys by a State survey
agency to determine whether it continues to meet these conditions.
However, there is an alternative to certification surveys by State
agencies. Accreditation by an approved, nationally recognized Medicare
accreditation program may substitute for both initial and ongoing
review.
Section 1865(a)(1) of the Act provides that, if the Secretary of
the Department of Health and Human Services finds that accreditation of
a provider entity by an approved national accreditation organization
demonstrates that all applicable Medicare conditions or requirements
are met or exceeded, we will deem those provider entities as having met
such requirements. Accreditation by an accrediting organization is
voluntary and is not required for Medicare participation.
Subpart A of part 488 requires in part that a national accrediting
organization applying for approval of its Medicare accreditation
program provide us with reasonable assurance that the accrediting
organization requires its
[[Page 16004]]
accredited provider entities to meet requirements that are at least as
stringent as the Medicare conditions. Our regulations concerning the
approval of accrediting organizations are set forth at Sec. 488.5.
Section 488.5(e)(2)(i) requires an accrediting organization to reapply
for continued approval of its Medicare accreditation program every 6
years or sooner as determined by CMS. The American Association for
Accreditation of Ambulatory Surgery Facilities' (AAAASF) current term
of approval for their RHC accreditation program expires March 23, 2022.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act requires that we publish, within
60 days of receipt of an organization's complete application, a notice
identifying the national accreditation body making the request,
describing the nature of the request, and providing at least a 30-day
public comment period. We have 210 days after the date of receipt of a
complete application to publish a notice announcing our approval or
denial of an application.
III. Provisions of the Proposed Notice
On October 15, 2021, we published a proposed notice in the Federal
Register (86 FR 57429) entitled ``Application from the American
Association for Accreditation of Ambulatory Surgery Facilities for
Continued Approval of its Rural Health Clinic (RHC) Accreditation
Program'' announcing AAAASF's request for continued approval of its
Medicare RHC accreditation program. In that notice, we detailed our
evaluation criteria. Under section 1865(a)(2) of the Act and per
Sec. Sec. 488.5 and 488.8(h), we conducted a review of AAAASF's
application in accordance with the criteria authorized by our
regulations, which include, but are not limited to the following:
An administrative review of AAAASF's: (1) Corporate
policies; (2) financial and human resources available to accomplish the
proposed surveys; (3) procedures for training, monitoring, and
evaluation of its RHC surveyors; (4) ability to investigate and respond
appropriately to complaints against accredited RHCs; and, (5) survey
review and decision-making process for accreditation.
The equivalency of AAAASF's standards for RHCs as compared
with CMS' RHC CoPs.
AAAASF's survey process to determine the following:
++ The composition of the survey team, surveyor qualifications, and
the ability of the organization to provide continuing survey training.
++ The comparability of AAAASF's processes to those of State
agencies, including survey frequency, and the ability to investigate
and respond appropriately to complaints against accredited RHCs.
++ AAAASF processes and procedures for monitoring RHCs found out of
compliance with AAAASF's program requirements. These monitoring
procedures are used only when AAAASF identifies noncompliance. If
noncompliance is identified through validation reviews or complaint
surveys, the State survey agency monitors corrections as specified at
Sec. 488.9(c).
++ AAAASF's capacity to report deficiencies to the surveyed RHCs
and respond to the RHC's plan of correction in a timely manner.
++ AAAASF's capacity to provide us with electronic data and reports
necessary for effective validation and assessment of the organization's
survey process.
++ The adequacy of AAAASF's staff and other resources, and its
financial viability.
++ AAAASF's capacity to adequately fund required surveys.
++ AAAASF's policies with respect to whether surveys are announced
or unannounced, to assure that surveys are unannounced.
++ AAAASF's policies and procedures to avoid conflicts of interest,
including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ AAAASF's agreement to provide us with a copy of the most current
accreditation survey together with any other information related to the
survey as we may require, including corrective action plans.
In accordance with section 1865(a)(3)(A) of the Act, the October
15, 2021 proposed notice also solicited public comments regarding
whether AAAASF's requirements met or exceeded the Medicare conditions
for certification for RHCs. The comments we received support the
approval of AAAASF for continued recognition as a national accrediting
organization for RHCs. We did not receive any comments opposing the
approval.
IV. Provisions of the Final Notice
A. Differences Between AAAASF's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared AAAASF's RHC accreditation requirements and survey
process with the Medicare conditions for certification of 42 CFR part
491 and the survey and certification process requirements of parts 488
and 489. Our review and evaluation of AAAASF's RHC application, which
were conducted as described in section III. of this final notice,
yielded the following areas where, as of the date of this notice,
AAAASF has completed revising its standards and survey processes in
order to meet the requirements at:
Section 491.7(a)(1) to ensure that their crosswalk and
standards included the requirement that an RHC must have a health care
staff that meets the requirements of Sec. 491.8.
Section 491.8(a)(2) to ensure that their crosswalk and
standards include the correct reference that a physician member of the
staff may be the owner of the RHC, an employee of the clinic or center,
or under agreement with the clinic or center to carry out the
responsibilities required under this section.
Section 491.9(b)(4) to include the correct reference to
Sec. 491.9(b)(2), identifying the group of professional personnel.
Section 491.9(c)(2) to include a reference to 42 CFR part
493.
Revised and clarified survey processes and organizational
policies, consistent with Sec. 488.5(a)(4)(i), to ensure all surveys
are unannounced. AAAASF clarified its organizational policies to
reflect that surveys are not conducted based on the availability of
administrators, clinic directors, or any other individual of authority,
and for the same reasons, are not delayed.
In accordance with comparability requirements to those of the State
Survey Agency at Sec. 488.5(a)(4)(ii), AAAASF's revised its policies,
procedures and survey processes to include:
Revising policies to ensure the sample of the medical
records used in surveyor guidance is consistent with the type of
medical records to be reviewed.
Providing a corrective action plan and clarifications to
AAAASF's policies to ensure that documentation of patient and staff
observations and record reviews include separate identifier keys used
to ensure the security of patients and staff.
Developing additional policies and procedures and surveyor
guides to clarify deficiency citations, specifically how surveyors
determine the appropriateness of the level of citation is assessed
during an RHC survey for compliance (that is, condition level v.
standard level deficiency citation) and in accordance with Sec.
488.26(b).
Section 488.5(a)(5) describing the method AAAASF uses for
determining
[[Page 16005]]
the size and composition of the RHC survey team and AAAASF's comparable
criteria on determining the parameters for each survey to be comparable
to those of the State Survey Agency as outlined per Sec. 488.5(a)(4).
B. Term of Approval
Based on our review and observations described in section III. of
this final notice, we approve AAAASF as a national accreditation
organization for RHCs that request participation in the Medicare
program. The decision announced in this final notice is effective March
23, 2022 through March 23, 2026. Due to travel restrictions and the
reprioritization of survey activities brought on by the 2019 Novel
Coronavirus Disease (COVID-19) Public Health Emergency (PHE), CMS was
unable to observe an RHC survey completed by AAAASF surveyors as part
of the application review process, which is typically one component of
the comparability evaluation. Therefore, we are providing AAAASF with a
shorter period of approval. Based on our discussions with AAAASF and
the information provided in its application, we are confident that
AAAASF will continue to ensure that its accredited RHCs will continue
to meet or exceed the required standards. While AAAASF has taken
actions based on the findings noted in section IV. of this final notice
(Differences Between AAAASF's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements), as
authorized under Sec. 488.8, we will continue ongoing review of
AAAASF's RHC survey processes and will conduct a survey observation
once the COVID-19 PHE has expired.
V. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. chapter 35).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Lynette Wilson, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: March 16, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2022-05910 Filed 3-18-22; 8:45 am]
BILLING CODE 4120-01-P